Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial.
- DOI
- 10.1136/rmdopen-2023-003659
- Published
- 2024 Apr 9
- Container
- RMD open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2023-003659,
title = {Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial.},
author = {den Broeder N and Verhoef L and de Man YA and Kok MR and Thurlings R and van der Weele W and van den Bemt BJ and van den Hoogen FH and van der Maas A and den Broeder AA},
year = {2024},
journal = {RMD open},
doi = {10.1136/rmdopen-2023-003659},
url = {https://doi.org/10.1136/rmdopen-2023-003659}
}RIS
TY - JOUR TI - Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial. AU - den Broeder N AU - Verhoef L AU - de Man YA AU - Kok MR AU - Thurlings R AU - van der Weele W AU - van den Bemt BJ AU - van den Hoogen FH AU - van der Maas A AU - den Broeder AA PY - 2024 JO - RMD open DO - 10.1136/rmdopen-2023-003659 UR - https://doi.org/10.1136/rmdopen-2023-003659 ER -
APA
N, D. B., L, V., YA, D. M., MR, K., R, T., W, V. D. W., BJ, V. D. B., FH, V. D. H., A, V. D. M., & AA, D. B. (2024). Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial.. RMD open. https://doi.org/10.1136/rmdopen-2023-003659
Source records
- pubmed · retrieved 2026-09-27T15:03:14.716Z